Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients

BACKGROUND: Sitagliptin is a DPP-4 inhibitor that became available for use in Japan three years ago. This study was conducted to identify the pleiotropic effects of sitagliptin other than blood glucose lowering in Japanese type 2 diabetes mellitus patients. METHODS: A retrospective, observational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Akira, Maeda, Hajime, Kanamori, Akira, Matoba, Kiyokazu, Jin, Yasuyuki, Minagawa, Fuyuki, Obana, Mitsuo, Iemitsu, Koutarou, Ito, Shogo, Amemiya, Hikaru, Kaneshiro, Mizuki, Takai, Masahiko, Kaneshige, Hideaki, Hoshino, Kazuhiko, Ishikawa, Masashi, Minami, Nobuaki, Takuma, Tetsuo, Sasai, Nobuo, Aoyagi, Sachio, Kawata, Takehiro, Mokubo, Atsuko, Takeda, Hiroshi, Honda, Shin, Machimura, Hideo, Motomiya, Tetsuya, Waseda, Manabu, Naka, Yoshikazu, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449427/
https://www.ncbi.nlm.nih.gov/pubmed/23024732
http://dx.doi.org/10.4021/jocmr1061w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449427/
https://www.ncbi.nlm.nih.gov/pubmed/23024732
http://dx.doi.org/10.4021/jocmr1061w

Ejemplares similares